Pathogenic mechanisms in the development of diffuse pulmonary fibrosis

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 9, 1996, Pages 1117-1126

  Selman, M ^a   Pardo, A ^b  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Adhesion molecules; Collagen; Extracellular matrix; Fibroblast; Lung fibrosis

Indexed keywords

COLLAGEN;

CELL DIVISION; FIBROBLAST; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG FIBROSIS; METABOLISM; PATHOLOGY; REVIEW;

CELL DIVISION; COLLAGEN; FIBROBLASTS; HUMANS; INFLAMMATION; PULMONARY FIBROSIS;

EID: 0030225225     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Selman M (1989). Pulmonary fibrosis: human and experimental disease. In: Rojkind M (Editor), Focus on Connective Tissue in Health and Disease. CRC Press Inc., Boca Raton, 123-188.
2. Crapo JD (1986). Morphologic changes in pulmonary oxygen toxicity. Annual Review of Physiology, 48: 869-885.
3. Fasske E & Morgenroth K (1983). Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis. Lung, 161: 133-140.
4. Selman M, Montaño M, Ramos C, Barrios R & Pérez-Tamayo R (1989). Experimental pulmonary fibrosis induced by paraquat plus oxygen in rats: a morphological and biochemical sequential study. Experimental and Molecular Pathology, 50: 147-166.
5. Bowden DH (1987). Macrophages, dusts, and pulmonary diseases. Experimental Lung Research, 12: 89-107.
6. Selman M, Chapela R & Raghu G (1993). Hypersensitivity pneumonitis: clinical manifestations, diagnosis, pathogenesis and therapeutic strategies. Seminars in Respiratory Medicine, 14: 353-364.
7. Thomas PD & Hunninghake GW (1987). Current concepts of the pathogenesis of sarcoidosis. American Review of Respiratory Diseases, 135: 747-760.
8. Kreiss K, Miller F, Newman LS, Ojo-Amaize EA, Rossman MD & Saltini C (1994). Chronic beryllium disease. From the workplace to cellular immunology, molecular immunogenetics, and back. Clinical Immunology and Immunopathology, 71: 123-129.
9. Hamacher J & Schaberg T (1994). Adhesion molecules in lung diseases. Lung, 172: 189-213.
10. Rochester CL & Elias JA (1993). Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders. Seminars in Respiratory Medicine, 14: 389-416.
11. Baggiolini M & Dahinden CA (1994). CC chemokines in allergic inflammation. Immunology Today, 15: 127-133.
12. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G & Walz A (1994). Elevated IL-8and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 149: 655-659.
13. Carre PC, Mortenson RL, King TE, Noble PW, Sable CL & Riches DWH (1991). Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. Journal of Clinical Investigation, 88: 1802-1810.
14. Pilewski JM & Albelda SM (1993). Adhesion molecules in the lung. American Review of Respiratory Diseases, 148 (Suppl): S31-S37.
15. Carlos TM & Harlan JM (1994). Leukocyte-endothelial adhesion molecules. Blood, 84: 2068-2101.
16. Shijubo N, Imai K, Aoki S, Hirasawa M, Sugawara H, Koba H, Tsujisaki M, Sugiyama T, Hinoda Y, Yachi A, Asakawa M & Suzuki A (1992). Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis. Clinical and Experimental Immunology, 89: 58-62.
17. Nakao A, Hasegawa Y, Tsuchiya Y & Shimokata K (1995). Expression of cell adhesion molecules in the lungs of patients with idiopathic pulmonary fibrosis. Chest, 108: 233-239.
18. Barquin N, Chou PM, Ramos C, Montaño M, Pardo A & Selman M (1996). Expression of ICAM-1 and integrins in a rat model of chronic interstitial lung fibrosis. Laboratory Investigation, 74: 143A.
19. Jason K (Editor) (1993). Cytokines of the lung. In: Lung Biology in Health and Disease. Vol. 61. Marcel Dekker Inc., New York.
20. Antoniades NH, Bravo M, Avila R, Neville J & Selman M (1990). Platelet-derived growth factor in idiopathic pulmonary fibrosis. Journal of Clinical Investigation, 86: 1055-1064.
21. Antoniades H, Bravo M, Galanopoulos T & Selman M (1991). Molecular basis for the role of platelet-derived growth factor in pulmonary fibrosis. In: Selman M & Barrios R (Editors), Interstitial Pulmonary Diseases. Selected Topics. CRC Press Inc., Boca Raton, 35-46.
22. Broekelmann TJ, Limper AH, Colby TV & McDonald JA (1991). Transforming growth factor beta1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proceedings of the National Academy of Sciences, USA, 88: 6642-6646.
23. Piguet PF, Ribaux C, Karpuz V, Grau GE & Kapanci Y (1993). Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. American Journal of Pathology, 143: 651-655.
24. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse MT, Jordana G & Gauldie J (1988). Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic lungs. American Review of Respiratory Diseases, 137: 579-584.
25. Raghu G, Chen YY, Rusch V & Rabinovitch PS (1988). Differential proliferation of fibroblasts cultured from normal and fibrotic lungs. American Review of Respiratory Diseases, 138: 703-708.
26. Rojas L, Montiel F, Montaño M, Selman M & Pardo A (1995). Expression of a 2.8 kb PDGF-B/c-sis transcript and synthesis of PDGF-like protein by human lung fibroblasts. Chest, 108: 240-245.
27. Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP & Lynch SE (1991). Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proceedings of the National Academy of Sciences, USA, 88: 565-569.
28. Kuhn C & McDonald JA (1991). The roles of myofibroblasts in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. American Journal of Pathology, 138: 1257-1265.
29. Ohta K, Mortenson RL, Clark RAF, Hirose N & King TE (1995). Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 152: 1659-1665.
30. Zhang K, Rekhter MD, Gordon D & Phan SH (1994). Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. American Journal of Pathology, 145: 114-125.
31. Elias JA, Zitnik RJ & Ray P (1992). Fibroblast immune-effector function. In: Phipps RP (Editor), Pulmonary Fibroblast Heterogeneity. CRC Press Inc., Boca Raton, 295-322.
32. Campos MG, Montaño M, Ramos C, Pardo A & Selman M (1995). Eosinophil chemotactic activity in the culture medium of fibroblasts from patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 151: A50.
33. Uhal BD, Joshi I, Mundle S, Pardo A & Selman M (1995). Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. American Journal of Physiology, 269 (Lung Cellular and Molecular Physiology, 13): L819-L828.
34. Panos RJ, Rubin JS, Csaky KG, Aaronson SA & Mason RJ (1993). Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast conditioned medium. Journal of Clinical Investigation, 92: 969-977.
35. Fulmer JD, Bienkowski RS, Cowan MJ, Breul SD, Bradley KM, Ferrans VJ, Roberts WC & Crystal RG (1980). Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis. American Review of Respiratory Diseases, 122: 289-301.
36. Selman M, Chapela R, Montaño M, Soto H & Dĩaz L (1982). Changes of collagen content in fibrotic lung disease. Archivos de Investigación Médica, 13: 93-100.
37. Selman M, Montaño M, Ramos C & Chapela R (1986). Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax, 41: 355-359.
38. Kirk JM, Da Costa PE, Turner-Warwick M, Littleton RJ & Laurent GJ (1986). Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis. Clinical Sciences, 70: 39-45.
39. Kuhn C, Boldt J, King TE, Crouch E, Vartio T & McDonald JA (1989). An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. American Review of Respiratory Diseases, 140: 1693-1703.
40. Starcher BC, Kuhn C & Overton JE (1978). Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. American Review of Respiratory Diseases, 117: 299-306.
41. Turino GM (1985). The lung parenchyma - a dynamic matrix. American Review of Respiratory Diseases, 132: 1324-1334.
42. Basset F, Ferrans VJ, Takemura T, Fukuda Y & Crystal RG (1986). Intraluminal fibrosis in interstitial lung disorders. American Journal of Pathology, 122: 443-461.
43. van-der-Rest M & Garrone R (1991). Collagen family of proteins. FASEB Journal, 5: 2814-2823.
44. Bienkowski RS (1991). Interstitial collagens. In: Crystal RG & West JB (Editors), The Lung: Scientific Foundations. Vol. 1. Raven Press, New York, 381-388.
45. Bateman ED, Turner-Warwick M & Adelman-Grill BC (1981). Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 36: 645-6 53.
46. Raghu G, Striker U, Hudson L & Striker GE (1985). Extracellular matrix in normal and fibrotic human lungs. American Review of Respiratory Diseases, 131: 281-289.
47. Madri JA & Furthmayr H (1980). Collagen polymorphism in the lung: an immunohistochemical study of pulmonary fibrosis. Human Pathology, 11: 333-366.
48. Specks U, Nerlich A, Colby TV, Wiest I & Timpl R (1995). Increased expression of type VI collagen in lung fibrosis. American Journal of Respiratory and Critical Care Medicine, 151: 1956-1964.
49. Kehrer JP & Witschi HP (1980). In vivo collagen accumulation in an experimental model of pulmonary fibrosis. Experimental Lung Research, 1: 259-265.
50. Hesterberg TW, Gerriets JE, Reiser KM, Jackson AC, Cross CE & Last JA (1981). Bleomycin-induced pulmonary fibrosis. Correlation of biochemical, physiological, and histological changes. Toxicology and Applied Pharmacology, 60: 360-367.
51. Raghu G & Kavanagh TJ (1991). The human lung fibroblast. In: Selman M & Barrios R (Editors), Interstitial Pulmonary Diseases. Selected Topics. CRC Press Inc., Boca Raton, 1-34.
52. Selman M, Montaño M, Ramos C, Chapela R, González G & Vadillo F (1988). Lung collagen metabolism and the clinical course of hypersensitivity pneumonitis. Chest, 94: 347-353.
53. Ramos C, Montaño M, González G, Vadillo F & Selman M (1988). Collagen metabolism in experimental lung silicosis. A trimodal behavior of collagenolysis. Lung, 166: 347-353.
54. Takahashi S & Koda K (1984). Radioimmunoassay of soluble and insoluble collagenases in fibrotic liver. Biochemical Joumal, 220: 157-164.
55. Montfort I & Pérez-Tamayo R (1978). Collagenase in experimental carbon tetrachloride cirrhosis of the liver. American Journal of Pathology, 92: 411-420.
56. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, Chu ML & Ditto J (1985). Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. Journal of Investigative Dermatology, 84: 384-390.
57. Brady AH (1975). Collagenase in scleroderma. Journal of Clinical Investigation, 56: 1175-1180.
58. Pardo A & Selman M (1991). The collagenase gene family. Relationships between collagenolytic activity and fibrogenesis. In: Selman M & Barrios R (Editors), Interstitial Pulmonary Diseases. Selected Topics. CRC Press Inc., Boca Raton, 75-98.
59. Montaño M, Ramos C, Gonzalez G, Pardo A & Selman M (1989). Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest, 96: 1115-1119.
60. Pardo A, Selman M, Ramírez R, Ramos C, Montaño M, Stricklin G & Raghu G (1992). Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest, 102: 1085-1089.